 | • レポートコード：MRC23Q38128 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（2-3日） • 産業分類：医薬品 |
| Single User | ￥435,000 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥870,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界のメシル酸パロキセチン市場について調査・分析し、世界のメシル酸パロキセチン市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（錠剤、カプセル、内服液）、用途別セグメント分析（大うつ病性障害(MDD)、パニック障害(PD)、強迫性障害(OCD)、全般性不安障害(GAD)、その他）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Solco Healthcare、Sebela Pharmaceuticals、Padagis、Synthon、Noven Pharmaceuticals、Tevaなどが含まれています。 世界のメシル酸パロキセチン市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、メシル酸パロキセチン市場規模を推定する際に考慮しました。本レポートは、メシル酸パロキセチンの世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、メシル酸パロキセチンに関するビジネス上の意思決定に役立てることを目的としています。 ・メシル酸パロキセチン市場の概要 - 製品の定義 - メシル酸パロキセチンのタイプ別セグメント - 世界のメシル酸パロキセチン市場規模：タイプ別分析（錠剤、カプセル、内服液） - メシル酸パロキセチンの用途別セグメント - 世界のメシル酸パロキセチン市場規模：用途別分析（大うつ病性障害(MDD)、パニック障害(PD)、強迫性障害(OCD)、全般性不安障害(GAD)、その他） - 世界のメシル酸パロキセチン市場規模予測（2018年-2029年） - メシル酸パロキセチンの平均価格推移（2018年-2029年） - 前提条件と制限事項 ・メーカー別競争状況 - メーカー別市場シェア - 世界の主要メーカー、業界ランキング分析 - メーカー別平均価格 - メシル酸パロキセチン市場の競争状況およびトレンド ・メシル酸パロキセチンの地域別市場規模 - 北米のメシル酸パロキセチン市場規模（2018年-2029年） - アメリカのメシル酸パロキセチン市場規模（2018年-2029年） - ヨーロッパのメシル酸パロキセチン市場規模（2018年-2029年） - アジア太平洋のメシル酸パロキセチン市場規模（2018年-2029年） - 中国のメシル酸パロキセチン市場規模（2018年-2029年） - 日本のメシル酸パロキセチン市場規模（2018年-2029年） - 韓国のメシル酸パロキセチン市場規模（2018年-2029年） - インドのメシル酸パロキセチン市場規模（2018年-2029年） - オーストラリアのメシル酸パロキセチン市場規模（2018年-2029年） - 中南米のメシル酸パロキセチン市場規模（2018年-2029年） - 中東・アフリカのメシル酸パロキセチン市場規模（2018年-2029年） ・タイプ別セグメント：錠剤、カプセル、内服液 - 世界のメシル酸パロキセチンのタイプ別販売量（2018年-2023年） - 世界のメシル酸パロキセチンのタイプ別売上（2018年-2023年） - 世界のメシル酸パロキセチンのタイプ別価格 ・用途別セグメント：大うつ病性障害(MDD)、パニック障害(PD)、強迫性障害(OCD)、全般性不安障害(GAD)、その他 - 世界のメシル酸パロキセチンの用途別販売量（2018年-2023年） - 世界のメシル酸パロキセチンの用途別売上（2018年-2023年） - 世界のメシル酸パロキセチンの用途別価格 ・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向 Solco Healthcare、Sebela Pharmaceuticals、Padagis、Synthon、Noven Pharmaceuticals、Teva ・産業チェーンと販売チャネルの分析 - メシル酸パロキセチン産業チェーン分析 - メシル酸パロキセチンの主要原材料 - メシル酸パロキセチンの販売チャネル - メシル酸パロキセチンのディストリビューター - メシル酸パロキセチンの主要顧客 ・メシル酸パロキセチン市場ダイナミクス - メシル酸パロキセチンの業界動向 - メシル酸パロキセチン市場の成長ドライバ、課題、阻害要因 ・調査成果および結論 ・調査方法とデータソース |
Highlights
The global Paroxetine Mesylate market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Paroxetine Mesylate is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Paroxetine Mesylate is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Paroxetine Mesylate include Solco Healthcare, Sebela Pharmaceuticals, Padagis, Synthon, Noven Pharmaceuticals and Teva, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Paroxetine Mesylate, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Paroxetine Mesylate.
The Paroxetine Mesylate market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Paroxetine Mesylate market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Paroxetine Mesylate manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Solco Healthcare
Sebela Pharmaceuticals
Padagis
Synthon
Noven Pharmaceuticals
Teva
Segment by Type
Tablet
Capsule
Oral Solution
Segment by Application
Major Depressive Disorder(MDD)
Panic Disorder(PD)
Obsessive-compulsive Disorder(OCD)
Generalized Anxiety Disorders(GAD)
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Paroxetine Mesylate manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Paroxetine Mesylate in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Paroxetine Mesylate Market Overview
1.1 Product Overview and Scope of Paroxetine Mesylate
1.2 Paroxetine Mesylate Segment by Type
1.2.1 Global Paroxetine Mesylate Market Value Comparison by Type (2023-2029)
1.2.2 Tablet
1.2.3 Capsule
1.2.4 Oral Solution
1.3 Paroxetine Mesylate Segment by Application
1.3.1 Global Paroxetine Mesylate Market Value by Application: (2023-2029)
1.3.2 Major Depressive Disorder(MDD)
1.3.3 Panic Disorder(PD)
1.3.4 Obsessive-compulsive Disorder(OCD)
1.3.5 Generalized Anxiety Disorders(GAD)
1.3.6 Others
1.4 Global Paroxetine Mesylate Market Size Estimates and Forecasts
1.4.1 Global Paroxetine Mesylate Revenue 2018-2029
1.4.2 Global Paroxetine Mesylate Sales 2018-2029
1.4.3 Global Paroxetine Mesylate Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Paroxetine Mesylate Market Competition by Manufacturers
2.1 Global Paroxetine Mesylate Sales Market Share by Manufacturers (2018-2023)
2.2 Global Paroxetine Mesylate Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Paroxetine Mesylate Average Price by Manufacturers (2018-2023)
2.4 Global Paroxetine Mesylate Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Paroxetine Mesylate, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Paroxetine Mesylate, Product Type & Application
2.7 Paroxetine Mesylate Market Competitive Situation and Trends
2.7.1 Paroxetine Mesylate Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Paroxetine Mesylate Players Market Share by Revenue
2.7.3 Global Paroxetine Mesylate Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Paroxetine Mesylate Retrospective Market Scenario by Region
3.1 Global Paroxetine Mesylate Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Paroxetine Mesylate Global Paroxetine Mesylate Sales by Region: 2018-2029
3.2.1 Global Paroxetine Mesylate Sales by Region: 2018-2023
3.2.2 Global Paroxetine Mesylate Sales by Region: 2024-2029
3.3 Global Paroxetine Mesylate Global Paroxetine Mesylate Revenue by Region: 2018-2029
3.3.1 Global Paroxetine Mesylate Revenue by Region: 2018-2023
3.3.2 Global Paroxetine Mesylate Revenue by Region: 2024-2029
3.4 North America Paroxetine Mesylate Market Facts & Figures by Country
3.4.1 North America Paroxetine Mesylate Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Paroxetine Mesylate Sales by Country (2018-2029)
3.4.3 North America Paroxetine Mesylate Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Paroxetine Mesylate Market Facts & Figures by Country
3.5.1 Europe Paroxetine Mesylate Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Paroxetine Mesylate Sales by Country (2018-2029)
3.5.3 Europe Paroxetine Mesylate Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Paroxetine Mesylate Market Facts & Figures by Country
3.6.1 Asia Pacific Paroxetine Mesylate Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Paroxetine Mesylate Sales by Country (2018-2029)
3.6.3 Asia Pacific Paroxetine Mesylate Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Paroxetine Mesylate Market Facts & Figures by Country
3.7.1 Latin America Paroxetine Mesylate Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Paroxetine Mesylate Sales by Country (2018-2029)
3.7.3 Latin America Paroxetine Mesylate Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Paroxetine Mesylate Market Facts & Figures by Country
3.8.1 Middle East and Africa Paroxetine Mesylate Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Paroxetine Mesylate Sales by Country (2018-2029)
3.8.3 Middle East and Africa Paroxetine Mesylate Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Paroxetine Mesylate Sales by Type (2018-2029)
4.1.1 Global Paroxetine Mesylate Sales by Type (2018-2023)
4.1.2 Global Paroxetine Mesylate Sales by Type (2024-2029)
4.1.3 Global Paroxetine Mesylate Sales Market Share by Type (2018-2029)
4.2 Global Paroxetine Mesylate Revenue by Type (2018-2029)
4.2.1 Global Paroxetine Mesylate Revenue by Type (2018-2023)
4.2.2 Global Paroxetine Mesylate Revenue by Type (2024-2029)
4.2.3 Global Paroxetine Mesylate Revenue Market Share by Type (2018-2029)
4.3 Global Paroxetine Mesylate Price by Type (2018-2029)
5 Segment by Application
5.1 Global Paroxetine Mesylate Sales by Application (2018-2029)
5.1.1 Global Paroxetine Mesylate Sales by Application (2018-2023)
5.1.2 Global Paroxetine Mesylate Sales by Application (2024-2029)
5.1.3 Global Paroxetine Mesylate Sales Market Share by Application (2018-2029)
5.2 Global Paroxetine Mesylate Revenue by Application (2018-2029)
5.2.1 Global Paroxetine Mesylate Revenue by Application (2018-2023)
5.2.2 Global Paroxetine Mesylate Revenue by Application (2024-2029)
5.2.3 Global Paroxetine Mesylate Revenue Market Share by Application (2018-2029)
5.3 Global Paroxetine Mesylate Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Solco Healthcare
6.1.1 Solco Healthcare Corporation Information
6.1.2 Solco Healthcare Description and Business Overview
6.1.3 Solco Healthcare Paroxetine Mesylate Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Solco Healthcare Paroxetine Mesylate Product Portfolio
6.1.5 Solco Healthcare Recent Developments/Updates
6.2 Sebela Pharmaceuticals
6.2.1 Sebela Pharmaceuticals Corporation Information
6.2.2 Sebela Pharmaceuticals Description and Business Overview
6.2.3 Sebela Pharmaceuticals Paroxetine Mesylate Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Sebela Pharmaceuticals Paroxetine Mesylate Product Portfolio
6.2.5 Sebela Pharmaceuticals Recent Developments/Updates
6.3 Padagis
6.3.1 Padagis Corporation Information
6.3.2 Padagis Description and Business Overview
6.3.3 Padagis Paroxetine Mesylate Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Padagis Paroxetine Mesylate Product Portfolio
6.3.5 Padagis Recent Developments/Updates
6.4 Synthon
6.4.1 Synthon Corporation Information
6.4.2 Synthon Description and Business Overview
6.4.3 Synthon Paroxetine Mesylate Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Synthon Paroxetine Mesylate Product Portfolio
6.4.5 Synthon Recent Developments/Updates
6.5 Noven Pharmaceuticals
6.5.1 Noven Pharmaceuticals Corporation Information
6.5.2 Noven Pharmaceuticals Description and Business Overview
6.5.3 Noven Pharmaceuticals Paroxetine Mesylate Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Noven Pharmaceuticals Paroxetine Mesylate Product Portfolio
6.5.5 Noven Pharmaceuticals Recent Developments/Updates
6.6 Teva
6.6.1 Teva Corporation Information
6.6.2 Teva Description and Business Overview
6.6.3 Teva Paroxetine Mesylate Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Teva Paroxetine Mesylate Product Portfolio
6.6.5 Teva Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Paroxetine Mesylate Industry Chain Analysis
7.2 Paroxetine Mesylate Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Paroxetine Mesylate Production Mode & Process
7.4 Paroxetine Mesylate Sales and Marketing
7.4.1 Paroxetine Mesylate Sales Channels
7.4.2 Paroxetine Mesylate Distributors
7.5 Paroxetine Mesylate Customers
8 Paroxetine Mesylate Market Dynamics
8.1 Paroxetine Mesylate Industry Trends
8.2 Paroxetine Mesylate Market Drivers
8.3 Paroxetine Mesylate Market Challenges
8.4 Paroxetine Mesylate Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer